Phosphorylase kinase G2 (PHKG2) can be used as a biomarker for thyroid cancer [56], endometrial cancer [57], renal clear cell carcinoma [58] and colorectal cancer [59]. Here, PHKG2 is linked to thyroid gland carcinoma.